Company: PACB
Filing Date: 2025-04-23
Form Type: DEF 14A
Source: 0001299130-25-000090
Chunk: 17

Company: PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Filing Date: 2025-04-23
Form: DEF 14A
Chunk 17
---
 to attend. All of the members of our Board of Directors then serving attended our 2024 Annual Meeting of Stockholders.

The names of the nominees and directors, their ages as of April 10, 2025, and certain other information about them are set forth below:

| Name of Director          |     | Age |     | Position                                        |     | Class and Current Term       |
| William Ericson           |     |  66 |     | Director                                        |     | Class III, term expires 2025 |
| Christian O. Henry        |     |  57 |     | Director, President and Chief Executive Officer |     | Class I, term expires 2026   |
| Randall Livingston        |     |  71 |     | Director                                        |     | Class II, term expires 2027  |
| John F. Milligan, Ph.D.   |     |  64 |     | Chairman of the Board of Directors              |     | Class I, term expires 2026   |
| Marshall Mohr             |     |  69 |     | Director                                        |     | Class II, term expires 2027  |
| Kathy Ordoñez             |     |  74 |     | Director                                        |     | Class III, term expires 2025 |
| Lucy Shapiro, Ph.D.       |     |  84 |     | Director                                        |     | Class I, term expires 2026   |
| Christopher M. Smith      |     |  62 |     | Director                                        |     | Class III, term expires 2025 |
| Hannah A. Valantine, M.D. |     |  73 |     | Director                                        |     | Class II, term expires 2027  |

Nominees for Class III Directors (Directors Continuing in Office until the 2025 Annual Meeting; Term For Which Nominated Expires in 2026)

| William Ericson |

William Ericson has been a member of our Board of Directors since 2004. Mr. Ericson has been the Founding Partner at Wildcat Venture Partners since 2016 where he focuses on investments in Digital Health. He has also been a Managing Partner at Mohr Davidow Ventures (MDV) since 2000. Mr. Ericson has also served as a director of Adamas Pharmaceuticals, Inc. from 2005 to 2021. Mr. Ericson holds a B.S.F.S. from Georgetown University School of Foreign Service